Table 2. Univariable and multivariable analyses of established predictors of extended-spectrum β-lactamase-producing Enterobacterales infection, University Hospital Basel, Switzerland, January 2010–December 2016 (n = 376).
Parameter | Cases (ESBL-positive) (n = 94) |
Controls (ESBL-negative) (n = 282) |
Univariable analyses | Multivariable analysesa | ||||||
---|---|---|---|---|---|---|---|---|---|---|
n | % | n | % | OR | 95% CI | p value | OR | 95% CI | p value | |
Parameters by Tumbarello et al. [ 11 ] | ||||||||||
Recent hospitalisationb | 60 | 64 | 135 | 48 | 2.16 | 1.27–3.69 | 0.005 | NS | NA | NA |
Admission from other healthcare facility | 17 | 18 | 26 | 9 | 2.18 | 1.12–4.25 | 0.023 | 3.07 | 1.37–6.88 | 0.007 |
Antibiotic therapy with β-lactams or fluoroquinolonesc | 60 | 64 | 74 | 26 | 4.96 | 3.02–8.16 | < 0.001 | 4.10 | 2.17–7.74 | < 0.001 |
Urinary catheterisationd | 28 | 30 | 47 | 17 | 2.17 | 1.25–3.77 | 0.006 | NS | NA | NA |
Charlson Comorbidity Index ≥ 4 | 16 | 17 | 44 | 16 | 1.10 | 0.59–2.05 | 0.767 | NS | NA | NA |
Age ≥ 70 years | 47 | 50 | 165 | 59 | 1.21 | 0.75–1.95 | 0.444 | NS | NA | NA |
Parameters by Goodman et al. [ 12 ] | ||||||||||
History of ESBL-PE colonisation/infectione | 32 | 34 | 8 | 3 | 18.06 | 7.02–46.47 | < 0.001 | 15.32 | 5.52–42.53 | < 0.001f |
Hospitalisation in ESBL high-burden regione,g | 1 | 1 | 2 | 1 | 1.50 | 0.14–16.54 | 0.741 | NS | NA | NA |
Chronic indwelling vascular hardwareh | 21 | 22 | 45 | 16 | 1.61 | 0.86–3.00 | 0.136 | NS | NA | NA |
Any antibiotic exposure within last 6 monthsi | 56 | 60 | 74 | 26 | 5.85 | 3.21–10.64 | < 0.001 | NS | NA | NA |
Age ≥ 43 years | 87 | 93 | 260 | 92 | 1.25 | 0.49–3.20 | 0.647 | NS | NA | NA |
CI: confidence interval; ESBL: extended-spectrum β-lactamase; ESBL-PE: extended-spectrum β-lactamase-producing Enterobacterales; OR: odds ratio NA: not applicable; NS: not selected.
a Multivariable analyses included all variables presented in the table, only variables chosen by stepwise logistic regression using stepwise forward and backward selection, as well as Akaike information criterion (AIC), are presented in the table.
b More than 2 days within 12 months before index hospitalisation.
c Lasting > 48 h during the 3 months preceding admission.
d Within 30 days before index blood culture.
e Within 6 months before index hospitalisation.
f Selected by lasso regression and recursive partitioning algorithms (decision tree statistics).
g India (1), France (1) and North Macedonia (1).
h Central venous catheters (including peripherally inserted central catheter (PICC)-lines, ports, pace makers) and central dialysis catheters.
i Extended-spectrum penicillins, third/fourth generation cephalosporins, carbapenems, aztreonam, fluoroquinolones and aminoglycosides.
Bold print indicates significant p values.